// App-Quantinova.ai

1767 : The Effect on Health-Related Quality of Life of Treatment for Remission Maintenance in ANCA-Associated Vasculitis Beyond 18 Months

Researchers

Presenter

  • Gunnar Tomasson

Principal Investigators

  • Antoine G. Sreih

  • David Cuthbertson

  • Simon Carette

  • Nader A. Khalidi

  • Curry L. Koening

  • Carol A. Langford

  • Carol A. McAlear

  • Paul A. Monach

  • Larry W. Moreland

  • Philip Seo

  • Ulrich Specks

  • Steven R. Ytterberg

  • Peter A. Merkel

Medical Centers

  • Univ. of Iceland Faculty of Medicine, Reykjavik, Iceland

  • Ophthalmology, University of Pennsylvania, Philadelphia, PA

  • Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL

  • Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

  • Rheumatology, McMaster University, Hamilton, ON, Canada

  • Neurology, Univ of Utah, Salt Lake City, UT

  • Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH

  • University of Pennsylvania, Philadelphia, PA

  • Tufts University School of Medicine, Boston, MA

  • Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

  • Johns Hopkins University, Baltimore, MD

  • Mayo Clinic College of Medicine, Rochester, MN

  • Hematology, Mayo Clinic, Rochester,

  • Biostatistics, Epidemiology, and Bioinformatics, University of Pennsylvania, Philadelphia, PA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Oraprine

  • Methotrexate

  • Infliximab

  • Rituximab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved